Kathleen Ann Laflen, EDS in Bennington, KS - Psychologist

Kathleen Ann Laflen, EDS is a Psychologist - School based in Bennington, Kansas. Kathleen Ann Laflen is licensed to practice in Kansas (license number 9726732514) and her current practice location is 605 N Stark St, Bennington, Kansas. She can be reached at her office (for appointments etc.) via phone at (785) 488-5106.

NPI number for Kathleen Ann Laflen is 1336833185 and her current mailing address is 605 N Stark St, Bennington, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1336833185.

Contact Information

	Kathleen Ann Laflen, EDS
	605 N Stark St, Bennington, KS 67422-9430
	(785) 488-5106
	Not Available

Healthcare Provider's Profile

Full Name	Kathleen Ann Laflen
Gender	Female
Speciality	Psychologist - School
Location	605 N Stark St, Bennington, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1336833185
Provider Enumeration Date: 06/05/2023
Last Update Date: 06/20/2023

Medical Identifiers

Medical identifiers for Kathleen Ann Laflen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336833185	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TS0200X	Psychologist - School	9726732514 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kathleen Ann Laflen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kathleen Ann Laflen, EDS 605 N Stark St, Bennington, KS 67422-9430 Ph: (785) 342-1987	Kathleen Ann Laflen, EDS 605 N Stark St, Bennington, KS 67422-9430 Ph: (785) 488-5106

News Archive

New clinical and prognostic characteristics discovered in solid organ recipients with COVID-19

Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.

Vertical farms could solve food production problems, opinion piece says

"If climate change and population growth progress at their current pace, in roughly 50 years farming as we know it will no longer exist," which means that the "majority of people could soon be without enough food or water," Dickson Despommier, a professor of public health at Columbia University, warns in a New York Times opinion piece

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces top-line results from REFRESH, a phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

MRSA nasal colonization associated with increase in SSI in patients undergoing GI surgery

Methicillin-resistant Staphylococcus (MRSA) nasal colonization is associated with longer hospital stays and an increase in surgical site infections (SSI) in patients undergoing major gastrointestinal surgery, according to a new study from Scott and White Memorial Hospital, Temple, TX.

Children with mild to moderate kidney disease have carotid atherosclerosis

A federally funded study led by researchers at Johns Hopkins Children's Center has found that children with mild to moderate kidney disease have abnormally thick neck arteries, a condition known as carotid atherosclerosis, usually seen in older adults with a long history of elevated cholesterol and untreated hypertension.

Kathleen Ann Laflen, EDS - Psychologist in Bennington, KS